Onderneming Auris Medical Holding Ltd Nasdaq
Aandelen
BMG070251027
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01-04-03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01-11-21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Samuel Wickline
CTO | Chief Tech/Sci/R&D Officer | 71 | 01-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01-03-18 |
Mats Blom
BRD | Director/Board Member | 59 | 01-04-17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01-04-03 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 240 245 | 2 220 245 ( 99,11 %) | 0 | 99,11 % |
Bedrijfsgegevens
Altamira Therapeutics Ltd.
Clarendon House 2 Church Street
HM 11, Hamilton
+441 295 5950
http://www.altamiratherapeutics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 114 mld. | |
+11,60% | 105 mld. | |
-4,68% | 23,83 mld. | |
-0,82% | 21,73 mld. | |
-10,12% | 18,1 mld. | |
-42,12% | 16,34 mld. | |
-17,47% | 16,13 mld. | |
+2,77% | 13,75 mld. | |
+34,58% | 11,76 mld. |